Real-world dosing of omalizumab for chronic spontaneous urticaria.

McIntyre, Amanda P; Viswanathan, Ravi K; Moss, Mark H; Mathur, Sameer K

McIntyre, Amanda P; Viswanathan, Ravi K; Moss, Mark H; Mathur, Sameer K.

Afiliación

McIntyre AP; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Viswanathan RK; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Moss MH; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Mathur SK; Division of Allergy, Pulmonary and Critical Care, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin. Electronic address: skmathur@wisc.edu.

Ann Allergy Asthma Immunol ; 124(2): 211-212, 2020 02.

Article en En | MEDLINE | ID: mdl-31805358

Asunto(s)

Antialérgicos/administración & dosificación; Urticaria Crónica/tratamiento farmacológico; Omalizumab/administración & dosificación; Urticaria Crónica/diagnóstico; Urticaria Crónica/etiología; Femenino; Humanos; Masculino; Resultado del Tratamiento

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antialérgicos / Omalizumab / Urticaria Crónica Tipo de estudio: Diagnostic_studies / Etiology_studies Límite: Female / Humans / Male Idioma: En Revista: Ann Allergy Asthma Immunol Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google